Diquafosol tetrasodium is a synthetic uridine derivative used primarily in the treatment of dry eye disease to help improve ocular surface conditions by stimulating tear and mucin secretion. As a P2Y2… Read more
Diquafosol tetrasodium is a synthetic uridine derivative used primarily in the treatment of dry eye disease to help improve ocular surface conditions by stimulating tear and mucin secretion. As a P2Y2 receptor agonist, this agent functions by promoting fluid transport and mucin release in the conjunctiva. Pharmaceutical laboratories rely on accurate reference standards of Diquafosol tetrasodium, including its identified impurities, metabolites, and stable isotope-labelled compounds, to support rigorous analytical testing and method validation. These high-quality materials are essential for impurity profiling, quantifying drug concentration, and ensuring quality control throughout the drug development process and regulatory submission. By utilizing these precise analytical tools, researchers can effectively monitor product stability and ensure adherence to safety standards, ultimately facilitating the reliable characterization of this therapeutic compound in complex matrices.